DD235638A5 - Neue neuromuskulaere blockierungsmittel - Google Patents

Neue neuromuskulaere blockierungsmittel Download PDF

Info

Publication number
DD235638A5
DD235638A5 DD85278691A DD27869185A DD235638A5 DD 235638 A5 DD235638 A5 DD 235638A5 DD 85278691 A DD85278691 A DD 85278691A DD 27869185 A DD27869185 A DD 27869185A DD 235638 A5 DD235638 A5 DD 235638A5
Authority
DD
German Democratic Republic
Prior art keywords
compound
formula
compounds
item
configuration
Prior art date
Application number
DD85278691A
Other languages
German (de)
English (en)
Inventor
Roy A Swaringen Jr
Hassan A El-Sayad
David A Yeowell
John J Savarese
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD235638A5 publication Critical patent/DD235638A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Jib Cranes (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Cephalosporin Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
DD85278691A 1984-07-18 1985-07-17 Neue neuromuskulaere blockierungsmittel DD235638A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (1)

Publication Number Publication Date
DD235638A5 true DD235638A5 (de) 1986-05-14

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85278691A DD235638A5 (de) 1984-07-18 1985-07-17 Neue neuromuskulaere blockierungsmittel

Country Status (30)

Country Link
US (1) US4761418A (lt)
EP (1) EP0181055B1 (lt)
JP (1) JPH0662568B2 (lt)
AT (1) ATE60759T1 (lt)
AU (1) AU574481B2 (lt)
BG (1) BG60411B2 (lt)
CA (1) CA1273341A (lt)
CY (1) CY1687A (lt)
DD (1) DD235638A5 (lt)
DE (2) DE19675039I2 (lt)
DK (1) DK168093B1 (lt)
ES (1) ES8609260A1 (lt)
FI (1) FI85019C (lt)
GB (1) GB8418303D0 (lt)
GE (1) GEP19960468B (lt)
HK (1) HK47593A (lt)
HU (1) HU193996B (lt)
IE (1) IE58138B1 (lt)
IL (1) IL75833A (lt)
LT (1) LT2078B (lt)
LU (1) LU88801I2 (lt)
LV (1) LV5483A3 (lt)
MC (1) MC1690A1 (lt)
MX (1) MX9203667A (lt)
NL (1) NL940023I2 (lt)
NZ (1) NZ212766A (lt)
PL (1) PL146066B1 (lt)
SG (1) SG3493G (lt)
SU (1) SU1468414A3 (lt)
ZA (1) ZA855407B (lt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
ES2210757T3 (es) * 1997-03-25 2004-07-01 Avera Pharmaceuticals, Inc. Isoquinolinas sustituidas como bloqueadores neuromusculares de accion ultracorta.
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
EP1684753A2 (en) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
BRPI0808272A2 (pt) * 2007-03-08 2014-07-08 Chemagis Ltd "método para cromatograficamente separar o isômero 1r-cis, 1´r-cis de uma mistura de isômeros de (1r-1'r) - atracúrio, besilato de cisatracúrio e isômero 1r-cis, 1'r-cis do besilato de cisatracúrio"
BRPI0808581A2 (pt) * 2007-03-26 2014-09-16 Chemagis Ltd "método para separar cisatracúrio com alta pureza de uma mistura de isômeros de (1r, 1'r) - atracúrio"
CA2685491A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
CA2685488A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
BRPI0811687A2 (pt) * 2007-06-18 2015-02-18 Chemagis Ltd MÉTODO PARA SEPARAR O ISÔMETRO 1R-CIS, 1'R-CIS (cisatracúrio) DE UMA MISTURA DE ISÔMEROS DE SAIS DE (1R, 1'R) - ATRACÚRIO
EP2176227A1 (en) * 2007-07-09 2010-04-21 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
BRPI0816519A2 (pt) * 2007-10-29 2015-03-24 Chemagis Ltd Processo para preparar um sal de r, r'-atracúrio isomericamente enriquecido e sal de r, r'-atracúrio
ITMI20080319A1 (it) 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
WO2009133556A2 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
WO2011022491A1 (en) 2009-08-19 2011-02-24 Cornell University Cysteine for physiological injection
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
ES2625329T3 (es) 2012-06-29 2017-07-19 Cornell University Agentes bloqueantes neuromusculares asimétricos reversibles de duración ultra-corta, corta o intermedia
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
BE869415A (fr) * 1977-08-01 1979-01-31 Massachusetts Gen Hospital Agents de blocage neuromusculaire
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
CA1153380A (en) * 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
EP0054309B1 (en) * 1980-12-17 1984-08-22 The Wellcome Foundation Limited Long duration neuromuscular blocking agents, pharmaceutical compositions containing them and processes for their preparation
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
FI85019B (fi) 1991-11-15
EP0181055A1 (en) 1986-05-14
SU1468414A3 (ru) 1989-03-23
LV5483A3 (lv) 1994-03-10
IL75833A0 (en) 1985-11-29
DE19675039I2 (de) 2003-01-09
IE58138B1 (en) 1993-07-14
MX9203667A (es) 1992-07-31
FI852807A0 (fi) 1985-07-17
CY1687A (en) 1993-10-10
GB8418303D0 (en) 1984-08-22
SG3493G (en) 1993-03-12
GEP19960468B (en) 1996-08-29
US4761418A (en) 1988-08-02
DK168093B1 (da) 1994-02-07
DE3581699D1 (de) 1991-03-14
ATE60759T1 (de) 1991-02-15
CA1273341A (en) 1990-08-28
HUT40626A (en) 1987-01-28
NZ212766A (en) 1988-03-30
HU193996B (en) 1987-12-28
JPH0662568B2 (ja) 1994-08-17
MC1690A1 (fr) 1986-07-18
ZA855407B (en) 1986-04-30
LU88801I2 (fr) 1996-11-05
FI85019C (fi) 1992-02-25
FI852807L (fi) 1986-01-19
AU4510885A (en) 1986-01-23
PL254571A1 (en) 1986-07-15
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30
BG60411B2 (bg) 1995-02-28
AU574481B2 (en) 1988-07-07
HK47593A (en) 1993-05-21
DK324985D0 (da) 1985-07-17
NL940023I1 (nl) 1995-01-02
LT2078B (lt) 1993-06-15
DK324985A (da) 1986-01-19
ES8609260A1 (es) 1986-09-01
IE851791L (en) 1986-01-18
EP0181055B1 (en) 1991-02-06
PL146066B1 (en) 1988-12-31
NL940023I2 (nl) 1998-06-02
JPS6187666A (ja) 1986-05-06

Similar Documents

Publication Publication Date Title
DD235638A5 (de) Neue neuromuskulaere blockierungsmittel
DE69830157T2 (de) Substituierte isochinoline als ultrakurz wirkende neuromuskuläre blocker
DE69119768T2 (de) Neuromuskuläre blocker
DE3010153C2 (lt)
DE3033896C2 (lt)
CH626345A5 (lt)
DE2113866C3 (de) (+-)-12-Oxo-2,3,5,6,12,13,13a,13boctahydro-1H-indolo[3,2,1-d,e]pyrido[3,2,1-i,j][1,5]naphthyridin, dessen Enantiomere und Salze, ein Verfahren zur Herstellung dieser Verbindung und diese Verbindungen enthaltende Arzneimitel
DE3546218A1 (de) Azoniaspironortropanolester, verfahren zu deren herstellung und pharmazeutisches mittel
DE3204960A1 (de) Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2632118A1 (de) Apovincaminolester und verfahren zu deren herstellung
DE3804936A1 (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE3226921C2 (de) Neue 3,7-Diazabicyclo[3.3.1]nonan Verbindungen und Verfahren zu ihrer Herstellung
DE3000625A1 (de) Cis- und trans-isomere von 3-aryloxy- 4-hydroxypyrrolidinen und deren derivaten, verfahren zu ihrer herstellung und ihre verwendung
DE68924545T2 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
CH668262A5 (de) (-)-1beta-aethyl-1alpha-(hydroxymethyl)-1,2,3,4,6,7,12,12balpha-octahydroindolo(2,3-a)chinolizin und verfahren zu seiner herstellung.
EP0353754B1 (de) Radioaktiv markierte Benzodiazepinderivate
DE2002107A1 (de) Neue organische Verbindungen und Verfahren zu deren Herstellung
DD210044A5 (de) Verfahren zur herstellung von trans-4ar-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-1h(und 2h)pyrazolo(3,4-g)-chinolinen
DE3046017C2 (de) Indolizin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung
AT379810B (de) Verfahren zur herstellung von neuen 3,7-diazabicyclo (3,3,1) nonanderivaten, deren stereoisomeren und physiologisch vertraeglichen saeureadditionssalzen
DE2421999C3 (de) Vincaminsäurederivate
DE1620407C (de) 3 Hydroxy 6 oxo-N phenylathyl morphinan (eis) verbindungen und ihre Salze sowie Verfahren zu deren Her stellung
CH626893A5 (en) Process for the preparation of pyrrolo[2,1-b]-3-benzazepines
DE2014860C3 (de) Phenothiazinderivate, deren Herstellung und pharmazeutische Zusammensetzungen
DE3039304A1 (de) Neuromuskulaere blocker und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20050718